BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 856 filers reported holding BAXTER INTL INC in Q2 2024. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $564 | -23.6% | 16,861 | -2.4% | 0.01% | -25.0% |
| Q1 2024 | $738 | +4.5% | 17,277 | -5.4% | 0.01% | 0.0% |
| Q4 2023 | $706 | -9.4% | 18,261 | -11.6% | 0.01% | -14.3% |
| Q3 2023 | $779 | -32.7% | 20,648 | -18.7% | 0.01% | -33.3% |
| Q2 2023 | $1,158 | +1.5% | 25,407 | +12.4% | 0.02% | -4.5% |
| Q1 2023 | $1,141 | -17.1% | 22,604 | -16.2% | 0.02% | -18.5% |
| Q4 2022 | $1,376 | -99.9% | 26,989 | +6.7% | 0.03% | -3.6% |
| Q3 2022 | $1,362,000 | +96.8% | 25,300 | +134.8% | 0.03% | +75.0% |
| Q2 2022 | $692,000 | -17.5% | 10,774 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $839,000 | -27.1% | 10,774 | -19.6% | 0.02% | -27.3% |
| Q4 2021 | $1,151,000 | +6.9% | 13,402 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $1,077,000 | +16.3% | 13,402 | +16.5% | 0.02% | 0.0% |
| Q2 2021 | $926,000 | -6.3% | 11,502 | -1.8% | 0.02% | -15.4% |
| Q1 2021 | $988,000 | +368.2% | 11,707 | +345.5% | 0.03% | +333.3% |
| Q4 2020 | $211,000 | -36.4% | 2,628 | -36.3% | 0.01% | -50.0% |
| Q3 2020 | $332,000 | -10.8% | 4,128 | -4.6% | 0.01% | -20.0% |
| Q2 2020 | $372,000 | +5.4% | 4,328 | -0.5% | 0.02% | -11.8% |
| Q1 2020 | $353,000 | -2.8% | 4,348 | 0.0% | 0.02% | +13.3% |
| Q4 2019 | $363,000 | -14.4% | 4,348 | -10.3% | 0.02% | -16.7% |
| Q3 2019 | $424,000 | +4.7% | 4,848 | -2.0% | 0.02% | 0.0% |
| Q2 2019 | $405,000 | -1.2% | 4,948 | -2.0% | 0.02% | -5.3% |
| Q1 2019 | $410,000 | +19.2% | 5,048 | -3.4% | 0.02% | +5.6% |
| Q4 2018 | $344,000 | -11.3% | 5,228 | +4.0% | 0.02% | -5.3% |
| Q3 2018 | $388,000 | -47.6% | 5,028 | -49.8% | 0.02% | -51.3% |
| Q2 2018 | $740,000 | -99.9% | 10,023 | 0.0% | 0.04% | +11.4% |
| Q1 2018 | $651,896,000 | -9.3% | 10,023 | -9.9% | 0.04% | -10.3% |
| Q4 2017 | $718,732,000 | +3.5% | 11,119 | +0.5% | 0.04% | -2.5% |
| Q3 2017 | $694,580,000 | +3.7% | 11,069 | 0.0% | 0.04% | 0.0% |
| Q2 2017 | $670,117,000 | +16.7% | 11,069 | 0.0% | 0.04% | +14.3% |
| Q1 2017 | $574,038,000 | +17.0% | 11,069 | 0.0% | 0.04% | +9.4% |
| Q4 2016 | $490,799,000 | -5.5% | 11,069 | +1.4% | 0.03% | -8.6% |
| Q3 2016 | $519,554,000 | +18.3% | 10,915 | +12.4% | 0.04% | +16.7% |
| Q2 2016 | $439,312,000 | +4.4% | 9,715 | -5.1% | 0.03% | 0.0% |
| Q1 2016 | $420,659,000 | +7.7% | 10,240 | 0.0% | 0.03% | +11.1% |
| Q4 2015 | $390,656,000 | +56.2% | 10,240 | +34.5% | 0.03% | +42.1% |
| Q3 2015 | $250,054,000 | -49.2% | 7,612 | +8.1% | 0.02% | -44.1% |
| Q2 2015 | $492,307,000 | -12.5% | 7,040 | -14.3% | 0.03% | -12.8% |
| Q1 2015 | $562,933,000 | -1.1% | 8,218 | +5.8% | 0.04% | -2.5% |
| Q4 2014 | $569,243,000 | +40.6% | 7,767 | +37.7% | 0.04% | +33.3% |
| Q3 2014 | $404,783,000 | -1.3% | 5,640 | -0.5% | 0.03% | -3.2% |
| Q2 2014 | $409,941,000 | +32.2% | 5,670 | +34.5% | 0.03% | +29.2% |
| Q1 2014 | $310,140,000 | -68.7% | 4,215 | -70.4% | 0.02% | -70.0% |
| Q4 2013 | $989,349,000 | +33.7% | 14,225 | +26.3% | 0.08% | +23.1% |
| Q3 2013 | $739,998,000 | -6.0% | 11,265 | -0.9% | 0.06% | -9.7% |
| Q2 2013 | $787,254,000 | – | 11,365 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 16,850,000 | $1,473,870,000 | 17.51% |
| SECTOR GAMMA AS | 472,305 | $41,313,000 | 6.98% |
| TSFG, LLC | 91,132 | $7,971,000 | 6.10% |
| Veritas Asset Management LLP | 6,386,849 | $558,658,000 | 5.44% |
| Palmer Knight Co | 64,636 | $5,654,000 | 4.80% |
| Triodos Investment Management BV | 193,700 | $16,943,000 | 4.30% |
| Progressive Investment Management Corp | 82,216 | $7,191,000 | 3.85% |
| Alphinity Investment Management Pty Ltd | 362,173 | $31,679,000 | 3.65% |
| HealthCor Management, L.P. | 1,032,820 | $90,341,000 | 3.42% |
| Sivik Global Healthcare LLC | 75,000 | $6,560,000 | 3.31% |